February 22-23, 2025, Hong KongShi Ying, Director of the Pharmacy Department at Shenzhen New Frontier United Family HospitalInvited to attend the 2025 Hong Kong Pharmaceutical Academic Annual Conference in Hong Kong, with the theme of "Gathering Innovation, Leading Transformation, and Building a New Era of Pharmacy", focusing on the innovative development and cooperation prospects of the Guangdong Hong Kong Macao Greater Bay Area in the field of pharmacy. Director Shi Ying shared valuable experience and insights from Shenzhen New Frontier United Family Hospital in clinical pharmacy services, innovative drug use, and cross-border medical innovation at the meeting, bringing rich regional perspectives to the attendees.

 

The purpose of this annual conference is to explore the latest developments and trends in the field of pharmacy, share valuable insights and new initiatives, and promote in-depth cooperation in the field of pharmacy in the Guangdong Hong Kong Macao Greater Bay Area. During the conference, many experts, scholars, and industry elites from the Guangdong Hong Kong Macao Greater Bay Area gathered together to discuss the future development and cooperation opportunities in the field of pharmacy.
Director Shi Ying pointed out in her sharing that Shenzhen New Frontier United Family Hospital, as a comprehensive hospital in the Guangdong Hong Kong Macao Greater Bay Area, has been committed to improving the quality and efficiency of clinical pharmaceutical services. The pharmacy department of the hospital has a highly qualified and specialized team of pharmacists who ensure the safety and effectiveness of patients' medication through measures such as pre-approval of each drug prescription, provision of basic drug information and consulting services. In addition, the hospital continues to improve the medical experience and is committed to providing patients with better quality medical services.
 

In terms of innovative drug use, Shenzhen New Frontier United Family Hospital actively responds to policy requirements and actively introduces innovative drugs and devices that are urgently needed in clinical practice and have been listed in Hong Kong and Macau. Director Shi Ying mentioned that the hospital has achieved significant results in cross-border medical innovation, such as successfully introducing the world's first new drug for vitiligo, Luketinib cream, providing patients with new treatment options. The introduction of this drug not only marks an important breakthrough for the hospital in cross-border medical services and innovative drug and equipment introduction, but also demonstrates the hospital's leading position in the field of innovative healthcare.
Director Shi Ying's sharing has attracted widespread attention and heated discussions among the attendees. Everyone agrees that emphasizing clinical pharmaceutical services and the cultivation of young pharmacists is crucial for the development of the pharmaceutical profession. The exploration and practice of clinical pharmaceutical services, innovative drug use, and cross-border medical innovation at United Family Hospital provide useful references and inspirations for the cooperation and development of pharmacy in the Guangdong Hong Kong Macao Greater Bay Area.
In addition, Director Shi Ying also stated that Shenzhen New Frontier United Family Hospital will continue to strengthen cooperation and exchanges with universities such as the Chinese University of Hong Kong (Shenzhen) School of Medicine, and jointly promote scientific research innovation and talent cultivation in the field of pharmacy. The hospital will carry out more specialized sharing between medical institutions in Shenzhen and Hong Kong in the cross-border medical field, and have more exchanges in improving medical services and scientific research projects, in order to make greater contributions to the pharmaceutical industry in the Guangdong Hong Kong Macao Greater Bay Area and even the whole country.
 

The 2025 Hong Kong Pharmaceutical Academic Annual Conference provides a valuable platform for pharmaceutical experts and industry elites in the Guangdong Hong Kong Macao Greater Bay Area to exchange ideas. The sharing by Shi Ying, Director of the Pharmacy Department at Shenzhen New Frontier United Family Hospital, not only showcased the hospital's innovative achievements and rich experience in the field of pharmacy, but also brought profound thinking and inspiration to the attendees. I believe that in the future, the pharmaceutical industry in the Guangdong Hong Kong Macao Greater Bay Area will achieve even more brilliant achievements through everyone's joint efforts.